Sakar Healthcare Limited (NSE:SAKAR)

Market Cap	7.15B
Revenue (ttm)	1.89B
Net Income (ttm)	197.61M
Shares Out	21.75M
EPS (ttm)	8.98
PE Ratio	36.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,402
Average Volume	10,581
Open	328.50
Previous Close	328.55
Day's Range	328.00 - 332.45
52-Week Range	210.10 - 380.80
Beta	0.01
RSI	43.98
Earnings Date	Aug 13, 2025

About Sakar Healthcare

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytoci...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 325
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAKAR

Financial Performance

In 2024, Sakar Healthcare's revenue was 1.78 billion, an increase of 15.19% compared to the previous year's 1.54 billion. Earnings were 175.02 million, an increase of 49.96%.